Although the molecular mechanisms underlying XPO5 overexpression and its associated tumorigenic activity remain unclear, amplification of XPO5 resulting from chromosome 6p polyploidy has been shown to be associated with gastric cancer [16]. The gene discussed is XPO5; the disease is gastric cancer.